Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dance Biopharm Inc.

www.dancebiopharm.com

Latest From Dance Biopharm Inc.

Venture Funding Deals: CNS Plays Are Attracting Investment

Polyneuron, Synerkine, Harmony, EIP Pharma and AITI Life Sciences all raised cash in recent weeks to tackle various conditions involving the nervous system. More recent venture funding deals... 

Financing StartUps and SMEs

Finance Watch: A One-Time Treatment For Heart Disease? Verve Raises $58.5m To Give It A Try

Private Company Edition: With academic muscle, Google cash and nanoparticles, and various CRISPR licenses, Verve will develop gene-editing therapies for coronary heart disease prevention. Also, Vividion raises an $82m series B and two Belgian companies bring in $77.8m in VC cash.

Financing StartUps and SMEs

Finance Watch: Morphic's 'Smooth' Progress With Oral Integrin Inhibitors Justifies $80m Series B

Private Company Edition: Morphic raises $80m to take its first two integrin inhibitors into the clinic for fibrosis and inflammatory bowel disease. Also, Hillhouse has a new $10.6bn private equity fund for health care and other investments, and Atreca closes a $125m Series C.

Financing Business Strategies

New Chinese JV Confident As It Tackles Inhaled Insulin

China’s Tonghua Dongbao Pharmaceutical is expanding its diabetes portfolio through a joint venture with Harmony Biopharm for a patented insulin inhaler, aiming to build its presence in the specialized therapeutic area and to expand from an API supplier to a full-range product developer.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Dance Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dance Biopharm Inc.
  • Senior Management
  • Anne Whitaker, PhD, CEO
    Michael Kaseta, CFO
    John Patton, PhD, CSO
    Melissa Rhodes, PhD, Chief Dev. Officer
  • Contact Info
  • Dance Biopharm Inc.
    Phone: (415) 769-4200
    2 Mint Plaza
    Ste. 804
    San Francisco, CA 94103
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register